• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    CAR T Cell Therapy Companies

    ID: MRFR/HC/6630-CR
    200 Pages
    Rahul Gotadki
    July 2025

    CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is an innovative approach in cancer treatment, where a patient's T-cells are genetically engineered to target and destroy cancer cells. Several companies are at the forefront of CAR-T cell therapy development and commercialization.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    CAR T Cell Therapy Market Research Report - Global Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the CAR T Cell Therapy Market


    CAR-T Cell Therapy Key Companies*Disclaimer: List of key companies in no particular orderLatest CAR-T cell therapy Companies Update

    • Bluebird Bio (US)

    • Intellia Therapeutics (US)

    • Noile-Immune Biotech (Japan)

    • Celgene Corporation (US)

    • Bellicum Pharmaceuticals, Inc. (US)

    • Novartis International AG (Swiss)

    • Celyad (Belgium)

    • Cellectis (France)

    • Servier Laboratories (France)

    • Pfizer Inc. (US)

    • Caribou Biosciences, Inc. (US)

    • Mereck KGaA (Germany)

    • Amgen Inc. (US)